• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

Meet the Tesla of Two Wheels

January 21, 2026

The Main Reason Not To Retire

January 20, 2026

The 8-Step Savings Roadmap I Wish My Parents Had

January 20, 2026
Facebook Twitter Instagram
Trending
  • Meet the Tesla of Two Wheels
  • The Main Reason Not To Retire
  • The 8-Step Savings Roadmap I Wish My Parents Had
  • These Jobs Pay Six Figures in 2026 — and It’s Relatively Easy to Land One
  • How I Scaled a Niche Conference From 80 to 800 Attendees
  • 5 Myths About Patents That Are Holding Entrepreneurs Back
  • How We Out-Innovated Industry Giants on a Tight Budget
  • What Startups Need to Learn from Fortune 500 Playbooks (and What They Shouldn’t)
Wednesday, January 21
Facebook Twitter Instagram
iSafeSpend
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
iSafeSpend
Home » ADRs End Mostly Higher, Missfresh and Mesoblast Trade Actively
Investing

ADRs End Mostly Higher, Missfresh and Mesoblast Trade Actively

News RoomBy News RoomAugust 7, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

By Denny Jacob

International stocks trading in New York closed mostly higher on Friday.

The S&P/BNY Mellon index of American depositary receipts edged up 0.2% to 156.41. The European index ticked up 0.1% to 149.96. The Asian index climbed 0.3% to 183.83. The Latin American index slipped 0.7% to 202.40, while the emerging-markets index was flat at 303.65.

Missfresh was among those whose ADRs traded actively.

The Chinese online grocery company soared 285% after it reported share-purchase agreements with two investors, an acquisition and the filing of its delayed 2022 annual report.

Mesoblast tumbled 59% after the Food and Drug Administration once again turned away the company’s remestemcel-L drug candidate for children with a potentially life-threatening bone marrow transplant complication, calling on the company to provide more data.

Write to Denny Jacob at [email protected]

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

5 Myths About Patents That Are Holding Entrepreneurs Back

Investing January 20, 2026

Here’s a Way for Entrepreneurs to Read More This Year

Investing January 19, 2026

If Business Travel Costs Are Eating into Your Bottom Line Then This AI Tool Could Save You Thousands

Investing January 18, 2026

Why Indiana’s Coach Eats the Same Chipotle Bowl Every Day

Investing January 17, 2026

Trust Your Instincts. They Matter More Than You Think.

Investing January 16, 2026

How This Founder Built a Celebrity Matchmaking Machine

Investing January 15, 2026
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

The Main Reason Not To Retire

January 20, 20260 Views

The 8-Step Savings Roadmap I Wish My Parents Had

January 20, 20260 Views

These Jobs Pay Six Figures in 2026 — and It’s Relatively Easy to Land One

January 20, 20260 Views

How I Scaled a Niche Conference From 80 to 800 Attendees

January 20, 20260 Views
Don't Miss

5 Myths About Patents That Are Holding Entrepreneurs Back

By News RoomJanuary 20, 2026

Entrepreneur Key Takeaways Many founders delay patents, thinking they are expensive, unnecessary, or only useful…

How We Out-Innovated Industry Giants on a Tight Budget

January 20, 2026

What Startups Need to Learn from Fortune 500 Playbooks (and What They Shouldn’t)

January 20, 2026

11 Reasons You Don’t Want to Retire in Florida — According to a Former Floridian

January 19, 2026
About Us

Your number 1 source for the latest finance, making money, saving money and budgeting. follow us now to get the news that matters to you.

We're accepting new partnerships right now.

Email Us: [email protected]

Our Picks

Meet the Tesla of Two Wheels

January 21, 2026

The Main Reason Not To Retire

January 20, 2026

The 8-Step Savings Roadmap I Wish My Parents Had

January 20, 2026
Most Popular

Looking for today’s lowest mortgage rate? Try 15-year terms | August 4, 2023

August 5, 20238 Views

Why Your Website Gets Clicks But No Customers

January 17, 20262 Views

I’m a CPA: 7 Tax Breaks Seniors Forget to Claim

January 16, 20262 Views
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2026 iSafeSpend. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.